Insider Trading April 29, 2026 05:42 PM

Intuitive Surgical Director Disposes of $291,886 in Common Stock

Amy L. Ladd executes two sales under a pre-arranged 10b5-1 trading plan amidst recent stock price volatility.

By Caleb Monroe ISRG IBM NOW
Intuitive Surgical Director Disposes of $291,886 in Common Stock
ISRG IBM NOW

Amy L. Ladd, a director at Intuitive Surgical Inc. (NASDAQ: ISRG), has completed the sale of common stock totaling $291,886. The divestment took place through two separate transactions conducted this week. These sales were performed in accordance with a pre-arranged 10b5-1 trading plan, which is currently scheduled to expire on January 29, 2027.The first transaction occurred on April 28, 2026, when Ms. Ladd sold 500 shares at a price of $473.46 per share. The second transaction followed on April 29, 2026, consisting of the sale of 119 additional shares at $463.50 each. Collectively, the shares were sold at prices ranging from $463.50 to $473.46. Following these transactions, Ms. Ladd's direct holdings in Intuitive Surgical common stock stand at 120 shares.

Key Points

  • Insider selling via 10b5-1 plan
  • Strong quarterly revenue and margin growth
  • Broader tech sector volatility following earnings

Amy L. Ladd, a member of the board of directors for Intuitive Surgical Inc. (NASDAQ: ISRG), has executed two transactions involving the sale of company common stock. The total value of these disposals amounted to $291,886. These moves were part of a structured 10b5-1 trading plan that is set to remain in effect until January 29, 2027.


Transaction Details

The selling activity was split across two consecutive days in late April 2026. On April 28, 2026, Ms. Ladd disposed of 500 shares, with each share priced at $473.46. The following day, April 29, 2026, an additional 119 shares were sold at a price of $463.50 per share. Throughout these two sessions, the stock was transacted within a price range between $463.50 and $473.46. After completing these sales, Ms. Ladd directly holds 120 shares of Intuitive Surgical common stock.


Market Context and Financial Performance

Intuitive Surgical, a leader in the medical robotics sector, currently maintains a market capitalization of $160.6 billion. However, the stock has faced recent downward pressure, trading at $453.83. This represents a decline of nearly 20% year-to-date, bringing the price close to its 52-week low of $427.84. Despite this pricing weakness, the company's financial health is characterized by a "GREAT" score according to InvestingPro.

The recent insider activity follows a period of robust financial reporting from the company. Intuitive Surgical reported quarterly results that exceeded analyst expectations across several key metrics:

  • Revenue: Sales grew by 23%, reaching $2.77 billion.
  • Earnings: Earnings per share rose by 38% to $2.50.
  • Margins: Gross margin improved to 67.8%, while operating margin reached 38.9%, both of which surpassed previous forecasts.

Wall Street analysts have maintained various positive outlooks following these results. Bernstein SocGen Group reiterated an Outperform rating with a price target of $750, and RBC Capital also held an Outperform rating with a $650 target. Additionally, Piper Sandler and Barclays both maintained Overweight ratings, setting price targets at $580 and $651, respectively.


Broader Tech Sector Trends

The movement in ISRG occurs alongside volatile shifts in the broader technology sector. Recent earnings from other major players have led to mixed market reactions. For instance, IBM exceeded both revenue and earnings expectations but maintained its existing guidance, which resulted in a 9.25% decline in its share price. Similarly, ServiceNow reported results slightly above Wall Street estimates but saw an 18% drop in share price after citing concerns regarding geopolitical tensions.


Key Points

  • Insider Divestment via Scheduled Plan: A director has sold a significant portion of her direct holdings through a pre-set 10b5-1 plan, which provides a structured exit rather than an immediate reaction to market shifts.
  • Strong Fundamental Metrics: Despite the recent stock price decline, the company's core financials, including a 23% increase in sales and improved operating margins, remain strong.
  • Sector Volatility: The broader tech and software sectors are experiencing significant volatility following earnings reports, as seen with IBM and ServiceNow.

Risks and Uncertainties

  • Stock Price Downward Trend: The stock is approaching its 52-week low and has lost nearly 20% of its value year-to-date, indicating market pressure on the medical robotics leader.
  • Geopolitical and Macroeconomic Headwinds: As noted in recent software sector earnings, geopolitical tensions remain a cited concern that can impact broader tech market stability.

Risks

  • Year-to-date stock price decline approaching 52-week lows
  • Geopolitical tensions affecting the technology sector

More from Insider Trading

Jabil Executive Executes Common Stock Sale Amid Recent Financial Gains May 4, 2026 Ultra Clean Holdings Executive Executes Significant Stock Dispositions May 4, 2026 Bank of Hawaii Director Executes Common Stock Sale Amid Shifting Analyst Outlooks May 4, 2026 Slide Insurance Holdings CFO Executes Stock Sales Amid Recent Earnings Growth May 4, 2026 Slide Insurance CEO Executes $2.87 Million Stock Sale via Pre-Arranged Trading Plan May 4, 2026